Abstract
The Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services, has awarded Sanofi Pasteur $226 million to develop egg-free influenza vaccines at its vaccine plant in Swiftwater, Pennsylvania. BARDA says the deal is part of its effort to prepare for the next influenza pandemic. Most flu vaccines are grown in eggs, but Sanofi already sells one biologic flu vaccine, Flublok Quadrivalent, made from recombinant DNA grown in cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
